Predict your next investment

Raynovent company logo
HEALTHCARE | Drug Development

See what CB Insights has to offer

Founded Year



Series B | Alive

Total Raised


Last Raised

$42.85M | 9 mos ago

About Raynovent

Raynovent is a subsidiary of Zhongsheng Pharma, is a drug development company that focuses on liver and respiratory diseases, which include ZSP1601, ZSYM007, ZSYM008, ZSP1603, ZSP1273, and others.

Raynovent Headquarter Location

Room 501, Building D, No. 288, Shenzhou Road Huangpu District

Shenzhen, Guangdong, 510700,



Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Raynovent

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Raynovent is included in 1 Expert Collection, including Biopharmaceuticals.



13,989 items

Companies involved in the research, development, and commercialization of chemically- or biologically-derived therapeutic & theranostic drugs. Excludes vitamins/supplements, CROs/clinical trial services.

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.